|
ARMC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.36589999813575E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.22919998810789E-09 |
| Normal-vs-Stage2 |
9.221600E-02 |
| Normal-vs-Stage3 |
1.656350E-01 |
| Normal-vs-Stage4 |
5.281200E-01 |
| Stage1-vs-Stage2 |
1.958610E-01 |
| Stage1-vs-Stage3 |
3.354000E-02 |
| Stage1-vs-Stage4 |
1.787950E-01 |
| Stage2-vs-Stage3 |
6.255200E-01 |
| Stage2-vs-Stage4 |
7.436400E-01 |
| Stage3-vs-Stage4 |
9.953800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12219999959251E-07 |
| Normal-vs-AfricanAmerican |
3.1537000000359E-06 |
| Normal-vs-Asian |
4.063200E-01 |
| Caucasian-vs-AfricanAmerican |
6.206200E-01 |
| Caucasian-vs-Asian |
7.722400E-01 |
| AfricanAmerican-vs-Asian |
6.184200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.43590045304154E-10 |
| Normal-vs-Female |
6.433900E-02 |
| Male-vs-Female |
9.969400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.122500E-03 |
| Normal-vs-Extreme_Weight |
2.89699997324533E-09 |
| Normal-vs-Obese |
2.797800E-03 |
| Normal-vs-Extreme_Obese |
5.006400E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.799000E-01 |
| Normal_Weight-vs-Obese |
4.241600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.020000E-01 |
| Extreme_Weight-vs-Obese |
4.149700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.992800E-01 |
| Obese-vs-Extreme_Obese |
5.292800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.644400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.24460000000293E-05 |
| Normal-vs-Age(61-80Yrs) |
7.08150005301889E-09 |
| Normal-vs-Age(81-100Yrs) |
1.635270E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.338400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.884000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.229230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.826300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.840800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.447600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.74650302500845E-11 |
| Normal-VS-Type2 PRCC |
2.197800E-02 |
| Normal-VS-KIRP CIMP |
9.460400E-01 |
| Normal-VS-Unclassified PRCC |
2.821500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.901600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.165570E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.669700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.724600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.407800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.752400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.68550000000068E-05 |
| Normal-vs-N1 |
9.852600E-01 |
| Normal-vs-N2 |
8.928600E-01 |
| N0-vs-N1 |
1.459660E-02 |
| N0-vs-N2 |
3.059600E-01 |
| N1-vs-N2 |
8.761600E-01 |
|
|
